Vivo Capital, LLC Mereo Biopharma Group PLC Transaction History

Vivo Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.33 - $1.69 $1.25 Million - $6.41 Million	-3,795,225 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.04 - $1.7 $3.24 Million - $5.29 Million	-3,111,964 Reduced 45.05%	3,795,225 $4.25 Million
Q3 2021 Nov 15, 2021	BUY	$2.2 - $3.17 $5.91 Million - $8.52 Million	2,686,251 Added 63.64%	6,907,189 $16.7 Million
Q4 2020 Feb 16, 2021	SELL	$1.95 - $3.6 $3.9 Million - $7.2 Million	-2,000,000 Reduced 32.15%	4,220,938 $15.1 Million
Q3 2020 Nov 13, 2020	BUY	$2.55 - $3.29 $13.9 Million - $17.9 Million	5,442,938 Added 699.61%	6,220,938 $16.3 Million
Q2 2020 Aug 14, 2020	BUY	$1.0 - $3.4 $778,000 - $2.65 Million	778,000 New	778,000 $2.38 Million

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $431M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.